四川科瑞德制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
26
NMPA:26
Drug Approvals
Benidipine Hydrochloride Tablets
- Product Name
- 盐酸贝尼地平片
- Approval Number
- 国药准字H20253801
- Approval Date
- Apr 1, 2025
NMPA
Perospirone Hydrochloride Tablets
- Product Name
- 盐酸哌罗匹隆片
- Approval Number
- 国药准字H20249452
- Approval Date
- Nov 22, 2024
NMPA
Tandospirone Citrate Tablets
- Product Name
- 枸橼酸坦度螺酮片
- Approval Number
- 国药准字H20247227
- Approval Date
- Sep 27, 2024
NMPA
Milnacipran Hydrochloride Tablets
- Product Name
- 盐酸米那普仑片
- Approval Number
- 国药准字H20234510
- Approval Date
- Mar 6, 2024
NMPA
Tizanidine Hydrochloride Orally Disintegrating Tablets
- Product Name
- 盐酸替扎尼定口腔崩解片
- Approval Number
- 国药准字H20140110
- Approval Date
- Feb 6, 2024
NMPA
Tizanidine Hydrochloride Orally Disintegrating Tablets
- Product Name
- 盐酸替扎尼定口腔崩解片
- Approval Number
- 国药准字H20140147
- Approval Date
- Feb 6, 2024
NMPA
Sodium Valproate Oral Solution
- Product Name
- 丙戊酸钠口服溶液
- Approval Number
- 国药准字H20233525
- Approval Date
- May 12, 2023
NMPA
Pamidronate Disodium For Injection
- Product Name
- 注射用帕米膦酸二钠
- Approval Number
- 国药准字H20067274
- Approval Date
- Mar 16, 2023
NMPA
Tandospirone Citrate Tablets
- Product Name
- 枸橼酸坦度螺酮片
- Approval Number
- 国药准字H20233174
- Approval Date
- Feb 14, 2023
NMPA
pipecuronium bromide for injection
- Product Name
- 注射用哌库溴铵
- Approval Number
- 国药准字H20084465
- Approval Date
- Nov 21, 2022
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found